ZA200605583B - Use of gallium to treat inflammatory arthritis - Google Patents

Use of gallium to treat inflammatory arthritis

Info

Publication number
ZA200605583B
ZA200605583B ZA200605583A ZA200605583A ZA200605583B ZA 200605583 B ZA200605583 B ZA 200605583B ZA 200605583 A ZA200605583 A ZA 200605583A ZA 200605583 A ZA200605583 A ZA 200605583A ZA 200605583 B ZA200605583 B ZA 200605583B
Authority
ZA
South Africa
Prior art keywords
gallium
inflammatory arthritis
treat inflammatory
treat
arthritis
Prior art date
Application number
ZA200605583A
Other languages
English (en)
Inventor
Louis R Bucalo
Sreedharan Sunil
Allamneni Krishna
Lawrence R Bernstein
Original Assignee
Titan Pharmaceuticals Inc
Lawrence R Bernstein
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Titan Pharmaceuticals Inc, Lawrence R Bernstein filed Critical Titan Pharmaceuticals Inc
Publication of ZA200605583B publication Critical patent/ZA200605583B/xx

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00Medicinal preparations containing inorganic active ingredients
    • A61K33/24Heavy metals; Compounds thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/28Compounds containing heavy metals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/555Heterocyclic compounds containing heavy metals, e.g. hemin, hematin, melarsoprol
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00Drugs for skeletal disorders
    • A61P19/02Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00Drugs for skeletal disorders
    • A61P19/08Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00Drugs for disorders of the muscular or neuromuscular system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/02Immunomodulators

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Rheumatology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Inorganic Chemistry (AREA)
  • Pain & Pain Management (AREA)
  • Neurology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
ZA200605583A 2003-12-17 2004-12-17 Use of gallium to treat inflammatory arthritis ZA200605583B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US53035303P 2003-12-17 2003-12-17

Publications (1)

Publication Number Publication Date
ZA200605583B true ZA200605583B (en) 2009-06-24

Family

ID=34700126

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA200605583A ZA200605583B (en) 2003-12-17 2004-12-17 Use of gallium to treat inflammatory arthritis

Country Status (9)

Country Link
US (1) US20050220895A1 (enExample)
EP (1) EP1694341A1 (enExample)
JP (1) JP2007514754A (enExample)
CN (1) CN1917889A (enExample)
AU (1) AU2004299126A1 (enExample)
CA (1) CA2550119A1 (enExample)
MX (1) MXPA06006801A (enExample)
WO (1) WO2005058331A1 (enExample)
ZA (1) ZA200605583B (enExample)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2003279067A1 (en) * 2002-09-23 2004-04-08 Genta Inc. Tri(alkylcarboxylato) gallium (iii) products and pharmaceutical compositions containing them
WO2007100382A2 (en) * 2005-10-27 2007-09-07 Bernstein Lawrence R Orally administrable gallium compositions and method of use
US20110038809A1 (en) * 2005-11-01 2011-02-17 Perl Daniel P Growth control of oral and superficial microorganisms using gallium compounds
CN101300033A (zh) * 2005-11-07 2008-11-05 泰坦医药品公司 用镓对不良肝脏病症的治疗和预防
US7993675B2 (en) 2006-05-10 2011-08-09 Medtronic Xomed, Inc. Solvating system and sealant for medical use in the sinuses and nasal passages
US20070264296A1 (en) * 2006-05-10 2007-11-15 Myntti Matthew F Biofilm extracellular polysachharide solvating system
US7976873B2 (en) 2006-05-10 2011-07-12 Medtronic Xomed, Inc. Extracellular polysaccharide solvating system for treatment of bacterial ear conditions
US7959943B2 (en) 2006-05-10 2011-06-14 Medtronics Xomed, Inc. Solvating system and sealant for medical use in the middle or inner ear
EP2099464B1 (en) 2006-11-09 2016-05-25 BERNSTEIN, Lawrence Richard Local administration of gallium compositions to treat pain
US8088095B2 (en) 2007-02-08 2012-01-03 Medtronic Xomed, Inc. Polymeric sealant for medical use
EP2526773A1 (en) * 2007-04-02 2012-11-28 Mount Sinai School Of Medicine Methods for preventing or treating infectious diseases using gallium compounds
EP2262509A4 (en) * 2008-03-07 2012-02-22 Lawrence Bernstein GALLIUM COMPOUNDS AND METHOD OF USE FOR THE TREATMENT OF INFLAMMATORY ENDURANCE
CA2727432C (en) 2008-06-12 2016-10-11 Medtronic Xomed, Inc. Method for treating chronic wounds with an extracellular polymeric substance solvating system
US20100086576A1 (en) * 2008-10-06 2010-04-08 Myntti Matthew F Antimicrobial composition and methods of making and using same
EP2413698A4 (en) * 2009-03-30 2013-07-10 Niiki Pharma Inc PROCESS FOR TREATING OSTEOPOROSIS
EP2706845B1 (en) 2011-05-10 2021-06-23 Next Science IP Holdings Pty Ltd Antimicrobial solid and methods of making and using same
US10889556B2 (en) 2016-03-08 2021-01-12 The Regents Of The University Of California Compositions and methods for inhibiting influenza RNA polymerase PA endonuclease
WO2017156194A1 (en) * 2016-03-08 2017-09-14 The Regents Of The University Of California Compositions and methods for inhibiting influenza rna polymerase pa endonuclease
CN110381945A (zh) * 2017-02-10 2019-10-25 阿尔图姆制药股份有限公司 口服给予的镓(iii)配合物的组合物
US10537661B2 (en) 2017-03-28 2020-01-21 DePuy Synthes Products, Inc. Orthopedic implant having a crystalline calcium phosphate coating and methods for making the same
US10537658B2 (en) 2017-03-28 2020-01-21 DePuy Synthes Products, Inc. Orthopedic implant having a crystalline gallium-containing hydroxyapatite coating and methods for making the same
WO2019226519A1 (en) 2018-05-24 2019-11-28 Celanese EVA Performance Polymers Corporation Implantable device for sustained release of a macromolecular drug compound
EP3801462A4 (en) 2018-05-24 2022-03-16 Celanese EVA Performance Polymers LLC Implantable device for sustained release of a macromolecular drug compound
WO2019222856A1 (en) 2018-05-24 2019-11-28 Nureva Inc. Method, apparatus and computer-readable media to manage semi-constant (persistent) sound sources in microphone pickup/focus zones
JP2024515220A (ja) 2021-04-26 2024-04-05 セラニーズ・イーブイエイ・パフォーマンス・ポリマーズ・エルエルシー 高分子薬剤化合物の持続放出用の埋め込み型デバイス

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3519361A1 (de) * 1985-05-30 1986-12-04 Boehringer Ingelheim International GmbH, 6507 Ingelheim (gamma)-ifn als wirkstoff zur hemmung (verhinderung) von abbauprozessen im knochen
EP0330799A1 (en) * 1988-03-03 1989-09-06 Schering Aktiengesellschaft A method for the treatment of arthritis and inflammatory joint diseases
US5258376A (en) * 1989-11-22 1993-11-02 Bernstein Lawrence R Pharmaceutical compositions of gallium complexes of 3-hydroxy-4-pyrones
US6004951A (en) * 1989-11-22 1999-12-21 Bernstein; Lawrence Richard Administration of gallium complexes of 3-hydroxy-4-pyrones to provide physiologically active gallium levels in a mammalian individual
US5175006A (en) * 1990-09-21 1992-12-29 The Ohio State University Method of treating arthritis using gallium compounds
EP0599881B1 (en) * 1991-07-25 1998-05-13 Philippe Collery Gallium (iii) complexes, process for their obtention and pharmaceutical compositions containing them
ES2151486T3 (es) * 1991-11-12 2001-01-01 Lawrence Richard Bernstein Composiciones farmaceuticas que contienen complejos de 3-hidroxi-4-pironas.
US5902825A (en) * 1997-01-07 1999-05-11 Mitreoak, Ltd. Composition and method for the palliation of pain associated with diseases of the bone and bone joints
US6303804B1 (en) * 1999-05-07 2001-10-16 Raytheon Company Environmentally benign bismuth-containing spin-on precursor materials
US6054600A (en) * 1999-05-07 2000-04-25 Raytheon Company Non-toxic solvent soluble group IV and V metal acid salt complexes using polyether acid anhydrides
JP2003510362A (ja) * 1999-10-04 2003-03-18 ローレンス・アール・バーンスタイン 細胞内原核生物、dnaウイルス及びレトロウイルスによる感染を治療するための、3−ヒドロキシ−4−ピロンのガリウム錯体
US20020068761A1 (en) * 1999-10-04 2002-06-06 Bernstein Lawrence R. Gallium complexes of 3-hydroxy-4-pyrones to treat mycobacterial infections

Also Published As

Publication number Publication date
CA2550119A1 (en) 2005-06-30
MXPA06006801A (es) 2007-01-26
US20050220895A1 (en) 2005-10-06
WO2005058331A1 (en) 2005-06-30
AU2004299126A1 (en) 2005-06-30
EP1694341A1 (en) 2006-08-30
CN1917889A (zh) 2007-02-21
JP2007514754A (ja) 2007-06-07

Similar Documents

Publication Publication Date Title
ZA200605583B (en) Use of gallium to treat inflammatory arthritis
ZA201207323B (en) Method of treatment of prophylaxis
EP1494990A4 (en) IMPROVED LIQUID COMPOSITIONS
EP1663222A4 (en) METHODS RELATING TO THE TREATMENT OF GIANCES
HUE045022T2 (hu) Eljárások és kompozíciók víz kezelésére
PT1694342T (pt) Métodos de utilização de gelsolina para tratar ou prevenir sepsia bacteriana
GB2408558B (en) Treatment of pipes
IL185114A0 (en) Use of vitamin d compounds to treat endometriosis
PL373523A1 (en) Indol-2-ones as selective inhibitors of cyclooxygenase-2
EP1912630A4 (en) COMPOSITIONS AND METHODS FOR REDUCING POSTOPERATIVE PAIN
EP1651643A4 (en) BICYCLIC COMPOUNDS AND COMPOSITIONS USED AS PDF INHIBITORS
PL1611068T3 (pl) Zastosowanie dyspergatorów do polepszenia utrzymania płynności betonu
HK1090568A (en) Use of gallium to treat inflammatory arthritis
IL164218A0 (en) Use of interleukin-19 to treat ovarian cancer
GB0408521D0 (en) Treatment of sepsis
GB0327975D0 (en) Methods of treatment
AU2003224720A8 (en) Use of resistin to treat hematopoietic disorders
EP1828687A4 (en) REDUCING ELECTRICAL CONSUMPTION
ZA200406777B (en) Production of abalone
GB0301609D0 (en) Improvements to power blocks
GB0319717D0 (en) Adding disinfectant to water
GB0302549D0 (en) Treatment of ferrous waste
GB0318862D0 (en) Improvments to self-sterilisation of surfaces
GB0316556D0 (en) Treatment of water
GB0409840D0 (en) Improvements to self-sterilisation of surfaces